Hemoglobin Concentration and Stroke Risk in Hemodialysis Hemoglobin Concentration and Stroke Risk in Hemodialysis
Might low hemoglobin concentrations contribute to the risk for hemorrhagic or ischemic stroke among hemodialysis patients?Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 13, 2018 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Terumo ’ s MicroVention wins expanded FDA indications for Sofia cath
Terumo (OTC:TRUMY;TYO:4543) subsidiary MicroVention said today it won FDA clearance for a new clinical indication for its Sofia catheter designed for intracranial access, now cleared for contact aspiration procedures to treat acute ischemic stroke. The company said it won CE Mark approval in the European Union for the aspiration in 2015, and that the device has been used there and in other parts of the world to treat acute ischemic stroke. “In my clinical experience the unequaled tracking performance and the increased reperfusion capability of the Sofia Catheter make a major difference when treati...
Source: Mass Device - June 12, 2018 Category: Medical Devices Authors: Fink Densford Tags: Catheters Food & Drug Administration (FDA) Neurological Regulatory/Compliance Vascular MicroVention-Terumo Inc. Source Type: news

MicroVention Announces FDA Clearance For Thrombectomy Device
SOFIA® Catheter; A New Device for the Revascularization of Patients with Acute Ischemic Stroke ALISO VIEJO, Calif., June 12, 2018 -- (Healthcare Sales & Marketing Network) -- MicroVention, Inc. a U.S.-based subsidiary of Terumo and a global neurova... Devices, Interventional, Neurology, FDA MicroVention, Terumo, SOFIA Catheter, stroke (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 12, 2018 Category: Pharmaceuticals Source Type: news

UC lands largest grant ever for emergency medicine
The University of Cincinnati has been awarded a $29 million grant to study a clot-busting drug used to treat acute ischemic stroke, the largest amount ever awarded to the College of Medicine ’s Department of Emergency Medicine. The grant by the National Institutes of Health will fund research on the effectiveness of combining a drug known as tissue plasminogen activator, or tPA, with the blood thinners argatroban or eptifibatide. Plans call for 110 hospitals to take part in the stud y run through… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 1, 2018 Category: Biotechnology Authors: Barrett J. Brunsman Source Type: news

Report: Extra insights, but no clear-cut answers from TAVR embolic protection studies
Data from two new studies has provided extra insights, but no clear-cut solution for predicting stroke and which patients should receive embolic protection devices during transcatheter aortic valve replacement procedures, according to a new Medscape report. Results from a meta-analysis of 1,285 patients indicated that the use of embolic protection devices during TAVR procedures did not reduce mortality, but was associated with a lowered rate of stroke at 30 days, according to the report. The decline was mainly driven by registry data and was not confirmed by randomized controlled trials, Medscape specified. Stroke was repo...
Source: Mass Device - May 31, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Catheters Clinical Trials Claret Medical Inc. Source Type: news

FDA Okays Robotic System to Detect Abnormal Brain Blood Flow FDA Okays Robotic System to Detect Abnormal Brain Blood Flow
The FDA has cleared a new ultrasound technology that could help physicians diagnose, triage and manage patients who present with vasospasm, acute ischemic stroke, and other neurologic disorders characterized by abnormal blood flow in the brain.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 30, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news

World No Tobacco Day 2018: Tobacco breaks hearts
Cairo, Egypt, 31 May – Every year, on 31 May, the World Health Organization (WHO) and partners mark World No Tobacco Day, highlighting the health and other risks associated with tobacco use, and advocating for effective policies to reduce tobacco consumption. This year, World No Tobacco Day focuses on tobacco and heart disease. The campaign’s slogan is “Tobacco breaks hearts. Choose health, not tobacco”. Tobacco use is one of the leading causes of premature death and disability worldwide. It is also a key risk factor for the development of coronary heart disease, stroke and peripheral vascular dise...
Source: WHO EMRO News - May 26, 2018 Category: Middle East Health Source Type: news

Mini stroke symptoms: Four ways to prevent a transient ischaemic attack happening
MINI stroke symptoms are the same as those of a stroke, but they tend to only last for a few minutes or hours. It ’s important to be aware of all the signs because a mini stroke could mean you’re at risk of having a full stroke in the near future, which can have fatal consequences. There are five ways to prevent one happening. (Source: Daily Express - Health)
Source: Daily Express - Health - May 25, 2018 Category: Consumer Health News Source Type: news

Heart doctors call for permission to provide therapy to stroke patients
(European Society of Cardiology) Heart doctors from the European Society of Cardiology (ESC) Council on Stroke are calling on national health authorities for permission to provide stroke patients with mechanical thrombectomy, a life-saving treatment for acute ischaemic stroke, in regions where there is a lack of trained specialists. Details of the proposal are presented today at EuroPCR 2018. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 25, 2018 Category: International Medicine & Public Health Source Type: news

Abbott ’s Amplatzer Stroke Reduction Data Is Strong at EuroPCR
Abbott Laboratories’ Amplatzer Amulet left atrial appendage (LAA) occlusion device has been shown at one year to reduce stroke by 57% as compared to the predicted stroke risk. The data also showed it was able to make this reduction without the need for lifetime blood thinners.  The Abbott Park IL-based company released the data at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions in Paris, and simultaneously published in EuroIntervention. More than 1,078 patients suffering from atrial fibrillation (Afib) were in the study with one-year-follow up. “The Amul...
Source: MDDI - May 24, 2018 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

Role of Blood Lipids in the Development of Ischemic Stroke Role of Blood Lipids in the Development of Ischemic Stroke
What roles do LDL cholesterol, HDL cholesterol, and triglycerides play in the development of ischemic stroke and its 3 main subtypes?Stroke (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 24, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

TIA, Minor Stroke Linked to Recurrent Stroke Out to 5 Years TIA, Minor Stroke Linked to Recurrent Stroke Out to 5 Years
Latest results from a large registry of patients with transient ischemic attack or minor stroke suggest that new strategies for further risk reduction are needed in this population.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 22, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

An Egg A Day Might Reduce Your Risk Of Heart Disease, Study Says
In this study however, they didn’t assess the risk of developing diabetes, which may be because diabetes is a newer disease in the Chinese population and there is not good documentation of who has it,” Richard said. Still, she noted, “this will be very important data for helping develop dietary prevention guidelines in China.” Cardiovascular disease, which takes the lives of 17.7 million people every year, is the leading cause of death and disability worldwide, according to the World Health Organization. Cardiovascular disease causes nearly a third — 31% — of all global deaths each year....
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 22, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Eggs Heart Disease Local TV Source Type: news

J & J ’ s Cerenovus wins FDA nod for Embotrap II revascularization device
Johnson & Johnson‘s (NYSE:JNJ) Cerenovus said today it won FDA 510(k) clearance for the Embotrap II revascularization device. The Irvine, Calif.-based J&J division said that the device is designed to quickly restore natural blood flow by retrieving emboli within the vasculature of the brain, using minimal compression to protect against further complications. Approval of the device came based on data from the Arise II study, in which investigators reported being able to restore blood flow in 80% of patients treated within three passes, and in approximately 50% within a single pass. More than 66% of p...
Source: Mass Device - May 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Neurological Regulatory/Compliance Vascular cerenovus johnsonandjohnson Source Type: news

Medtronic recalls select MindFrame Capture revascularization devices
The FDA today released a recall notice for a select number of Medtronic (NYSE:MDT) MindFrame Capture LP revascularization devices over issues with the delivery wire breaking or separating during use. The federal watchdog labeled the recall as a Class I, its most serious class of recall, which indicates the potential for serious injury or death. The Fridley, Minn.-based company’s MindFrame Capture LP device is designed to restore blood flow and remove blood clots within a blood vessel in the brain during acute ischemic stroke in patients who are ineligible or fail intravenous tissue plasminogen activator therapy. Medt...
Source: Mass Device - May 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Neurological Recalls Vascular Medtronic Source Type: news

Cerenovus receives fda clearance for next generation stent retriever device used to treat ischemic stroke
(Source: Johnson and Johnson)
Source: Johnson and Johnson - May 21, 2018 Category: Pharmaceuticals Source Type: news

Cerenovus Receives FDA Nod for EMBOTRAP II
Johnson & Johnson’s Cerenovus unit has received an FDA nod to market the EMBOTRAP II Revascularization Device. The device is a next generation stent retriever used to capture and remove life-threatening blood clots from the brain following an ischemic stroke. The EMBOTRAP II Device is designed to rapidly restore blood flow by gripping and retrieving clots within the neurovasculature, with minimal compression, protecting against further complications. The device is indicated for use within eight hours of stroke symptom onset. In the ARISE II study, which was submitted as part of the 510(k) application to FDA, neur...
Source: MDDI - May 21, 2018 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

CERENOVUS Receives FDA Clearance For Next Generation Stent Retriever Device Used To Treat Ischemic Stroke
EMBOTRAP II Revascularization Device Captures and Removes Life-threatening Blood Clots, Rapidly Restores Blood Flow IRVINE, Calif., May 21, 2018 -- (Healthcare Sales & Marketing Network) -- CERENOVUS, part of the Johnson & Johnson Medical Devices Compa... Devices, Interventional, Radiology, Neurology, FDA CERENOVUS, Johnson & Johnson, EMBOTRAP, Revascularization, thrombectomy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 21, 2018 Category: Pharmaceuticals Source Type: news

Mini stroke symptoms: Four signs you’re having a transient ischaemic attack
MINI STROKE symptoms are the same as those of a stroke, but they tend to only last for a few minutes or hours. It ’s important to be aware of all the signs because a mini stroke could mean you’re at risk of having a full stroke in the near future, which an have fatal consequences. (Source: Daily Express - Health)
Source: Daily Express - Health - May 18, 2018 Category: Consumer Health News Source Type: news

POINT: Success at Last for Dual Antiplatelet After Stroke, TIA POINT: Success at Last for Dual Antiplatelet After Stroke, TIA
A combination of clopidogrel plus aspirin reduced major ischemic events vs aspirin alone in patients with minor ischemic stroke or high-risk TIA in this long-awaited trial.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Clopidogrel & #43; Aspirin Cuts Ischemic Events in Stroke, TIA
THURSDAY, May 17, 2018 -- The combination of clopidogrel and aspirin is associated with reduced risk of major ischemic events but increased risk of major hemorrhage among patients with minor ischemic stroke or high-risk transient ischemic attack... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2018 Category: Pharmaceuticals Source Type: news

DAPT Helps Secondary Prevention After Minor Strokes (CME/CE)
(MedPage Today) -- But bleeding risk comes with the reduction in ischemic stroke, trial shows (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 17, 2018 Category: Cardiology Source Type: news

NeuroVasc Tech raises $6m in Series B
NeuroVasc Technologies said yesterday it closed a $6.3 million Series B preferred stock round. The round was joined by multiple investors, and led by ShangBay Capital, the Laguna Hills, Calif.-based company said. NeuroVasc Tech is developing treatments for neurovascular conditions with a focus on treating ischemic stroke, and currently has CE Mark approval in the European Union for its Versi mechanical thrombectomy system used to remove clots form the brain during acute ischemic stroke. The device does not yet have FDA clearance for use in the US, the company said. “NeuroVasc’s technologies may significantly im...
Source: Mass Device - May 17, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Funding Roundup Neurological Vascular NeuroVasc Technologies Source Type: news

Thrombolysis Benefits WAKE-UP Strokes Thrombolysis Benefits WAKE-UP Strokes
A new landmark study has shown a beneficial effect of tPA in patients who have ischemic stroke with an unknown time of onset selected by limited tissue damage on MRI.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 17, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Rescue Stenting for Failed Mechanical Thrombectomy Rescue Stenting for Failed Mechanical Thrombectomy
Recanalization failure effects nearly 30% of patients receiving mechanical thrombectomy for acute ischemic stroke. Is rescue stenting an effective strategy for these patients?Stroke (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

International study suggests combination therapy may prevent stroke in certain people
(NIH/National Institute of Neurological Disorders and Stroke) Results from an international clinical trial of more than 4880 participants, published in the New England Journal of Medicine, show that combining clopidogrel and aspirin following a small stroke or experiencing minor stroke symptoms decreases risk of a new stroke, heart attack or other ischemic event within 90 days. The combination therapy was also associated with an increase in major bleeding, although many of those episodes were non-fatal and did not occur in the brain. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 17, 2018 Category: International Medicine & Public Health Source Type: news

Drug Combo May Help Lower Danger After Mini-Stroke
The American Stroke Association reports that more than one-third of U.S. adults have had a transient ischemic attack/mini-stroke. (Source: WebMD Health)
Source: WebMD Health - May 16, 2018 Category: Consumer Health News Source Type: news

Intravenous tPA for Stroke: Putting the Controversy to Rest Intravenous tPA for Stroke: Putting the Controversy to Rest
Dr Mark Alberts addresses recent controversial statements by some cardiology colleagues and other medical specialists regarding the safety and efficacy of IV tPA in treating acute ischemic stroke.Medscape Neurology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 16, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Commentary Source Type: news

After'Mini-Stroke,' Drug Combo (Aspirin Plus Clopidogrel) Could Help Cut Odds for Major Attack
WEDNESDAY, May 16, 2018 -- A dual-drug approach after a " mini-stroke " might maximize a person's odds of avoiding a more major stroke in the months after, research shows. Minor strokes and events known as " transient ischemic attacks " (TIA), or... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 16, 2018 Category: General Medicine Source Type: news

Stroke prevention drug combo shows promise
If you've had a minor stroke or a transient ischemic stroke (TIA), taking the clot-preventing drug clopidogrel along with aspirin may lower your risk of having a major stroke within the next 90 days, according to new research published in The New England Journal of Medicine. (Source: World Pharma News)
Source: World Pharma News - May 16, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Stroke prevention drug combo shows promise, study says
(University of Texas at Austin) If you've had a minor stroke or a transient ischemic stroke (TIA), taking the clot-preventing drug clopidogrel along with aspirin may lower your risk of having a major stroke within the next 90 days, according to new research published in The New England Journal of Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2018 Category: International Medicine & Public Health Source Type: news

Digital health news briefs for 5/15/18
Machine learning helps docs view the brain.   Automated cerebrovascular imaging company iSchemaView has just released its latest product Rapid Aspect, a digital imaging tool that helps clinicians assess early signs of brain ischemia in stroke patients. The technology will automatically generate a standardized score for physicians based on ma chine learning algorithms. The product is designed to help doctors communicate the ischemic changes in a patient's brain, and determine if a patient needs a clot removal.   (Source: mobihealthnews)
Source: mobihealthnews - May 15, 2018 Category: Information Technology Source Type: news

Strokes From Clot on Watchman LAA Closure Device: OAC Insights Strokes From Clot on Watchman LAA Closure Device: OAC Insights
The risks for ischemic and hemorrhagic stroke climbed whenever thrombus was seen on the implanted left atrial appendage occluder, often after oral anticoagulants were halted, in a pooled analysis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 14, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

HRS 2018: Device-related blood clots with Boston Scientific ’ s Watchman implant
Data from a study of device-related blood clots and the Watchman cardiac implant made by Boston Scientific (NYSE:BSX), presented today at the annual meeting of the Heart Rhythm Society in Boston, indicate the need for aggressive management of patients at risk for device-related thrombosis. There were 74 incidences of DRT in 65 of the 1,739 Watchman patients examined in the study, or 3.7%; eight of those patients had multiple DRTs and two experienced embolic events (0.45%). There was no significant difference in mortality between patients with DRT and those without, according to the study. Lead author Dr. Vivek Reddy, ...
Source: Mass Device - May 11, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Boston Scientific HRS 2018 Source Type: news

HRS 2018 Roundup: Device-related blood clots with Boston Scientific ’ s Watchman implant
Data from a study of device-related blood clots and the Watchman cardiac implant made by Boston Scientific (NYSE:BSX), presented today at the annual meeting of the Heart Rhythm Society in Boston, indicate the need for aggressive management of patients at risk for device-related thrombosis. There were 74 incidences of DRT in 65 of the 1,739 Watchman patients examined in the study, or 3.7%; eight of those patients had multiple DRTs and two experienced embolic events (0.45%). There was no significant difference in mortality between patients with DRT and those without, according to the study. Lead author Dr. Vivek Reddy, ...
Source: Mass Device - May 11, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Apple Bardy Diagnostics Boston Scientific Fitbit HRS 2018 Impulse Dynamics Imricor Medical Systems Inc. medicalgorithmics Medtronic Preventice samsung Source Type: news

Impact of NOACs on Ischemic Stroke Severity in AF Impact of NOACs on Ischemic Stroke Severity in AF
Can the use of non-vitamin K-dependent oral anticoagulants prior to stroke onset in patients with atrial fibrillation reduce the severity of stroke, if ischemic stroke should occur?Europace (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 11, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Penumbra shares rise on Q1 beat, growing sales
Shares in Penumbra (NYSE:PEN) rose today after the medical device maker topped expectations on Wall Street with its first quarter 2018 earnings results. The Alameda, Calif.-based company posted profits of $5.5 million, or 15¢ per share, on sales of $102.7 million for the three months ended March 31, seeing a swing from the red on the bottom line while sales grew 40.3% compared with the same period during the previous year. Earnings per share were well ahead of the 2¢ loss-per-share expectations on Wall Street, where analysts expected to see sales of $91.7 million, which the company also topped. Penumbra lift...
Source: Mass Device - May 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Penumbra Inc. Source Type: news

Stryker wins expanded CE Mark for Trevo stent retriever
Stryker (NYSE:SYK) said today that it won an expanded CE Mark indication in the European Union for its Trevo thrombectomy device as a front-line treatment for acute ischemic stroke patients for up to 24 hours from symptom onset. The expanded indication lifts the previously cleared treatment window by 18 hours, according to the Kalamazoo, Mich.-based company, and follows a similar move in February by the FDA. “Along with the expanded indication in the U.S., this expanded indication for Trevo in Europe marks a significant milestone in the treatment of stroke patients who suffer from this disease,” neuro...
Source: Mass Device - May 7, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Neurological Regulatory/Compliance Stroke Stryker Source Type: news

Stroke Triage: EMS needs a diagnostic tool that goes beyond a simple history & physical exam
As a young EMT and paramedic, I had relatively little education about acute myocardial infarctions. In the age of the 3-lead ECG, education was largely focused on arrhythmia detection and how to differentiate heart blocks, tachycardia and bradycardia. Detection of heart attack was largely based upon history and physical exam findings. Three decades later, the thought of relying on a physical exam to diagnose a ST- elevation myocardial infarction (STEMI) is hard to imagine. Although we’ve made remarkable progress in the prehospital detection of STEMI, we’ve made significantly less progress in the diagnosis of ac...
Source: JEMS Patient Care - May 2, 2018 Category: Emergency Medicine Authors: Mark E.A. Escott, MD, MPH, FACEP, NRP Tags: Patient Care Columns Source Type: news

Polk County (Fla.) Fire Rescue Protocol Includes Consideration for Wake-Up Strokes
Patients who awaken with stroke symptoms that weren’t present prior to falling asleep is a phenomenon known as wake-up stroke. Photo courtesy Raf Vittone   EMS was dispatched at 6:43 a.m. for a 47-year-old man who was experiencing right-sided paralysis. On arrival, the medics noticed that he couldn’t seem to understand them and thus wasn’t able to follow commands. The patient’s wife stated that her husband was perfectly normal when they went to bed at about 11 p.m. the previous night. Upon arrival at a primary stroke center, the time last known normal was acknowledged as 11 p.m., which meant ...
Source: JEMS Patient Care - May 2, 2018 Category: Emergency Medicine Authors: Paul R. Banerjee, DO Tags: Patient Care Cardiac & Resuscitation Source Type: news

Acute Stroke: From Prehospital Care to In-Hospital Management
Early recognition of stroke by clinical presentation and prehospital stroke assessment tools facilitate rapid prehospital and ED diagnosis. CanStockPhoto/focalpoint   Stroke is a leading cause of morbidity and mortality in the United States and requires prompt recognition by prehospital providers to ensure rapid transport. Stroke can present in a variety of different ways, some more readily apparent than others. Delays in diagnosis and treatment can have devastating effects on the outcomes for these patients. In this article, we describe a patient who initially presented with altered mental status and was subsequent...
Source: JEMS Patient Care - May 2, 2018 Category: Emergency Medicine Authors: Henry G. Colmer IV, MD Tags: Patient Care Cardiac & Resuscitation Source Type: news

A Tale of Two Telehealth Acquisitions
Telemedicine companies are actively looking for ways to open the sector up to broader adoption. Partnerships and acquisitions seem to be the fastest means to that end, as two recent telemedicine deals would suggest. InTouch Health, a Santa Barbara, CA-based telemedicine firm, said it will acquire REACH Health, an Alpharetta, GA-based telemedicine software company.  Shortly after the deal was announced, Boston, MA-based American Well, reported its agreement to acquire Avizia, a prominent player in the acute care telehealth space. Financial terms were not disclosed for either deal. "The telehealth industry is fragm...
Source: MDDI - May 2, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Digital Health Business Source Type: news

Blood Pressure Management Goals in Stroke Care
Blood pressure management goals in stroke care You arrive at a small rural emergency healthcare facility to transport a 72-year-old female who presents to the ED with the worst headache of her life. She’s to be transported to a tertiary center with neurosurgical services. Upon further questioning you determine her headache was sudden onset with maximum intensity. When reviewing her history and medications, you note that she’s currently on Coumadin (warfarin) with an international normalized ratio (INR) of 3.5, with the following vital signs noted on the monitor upon entering the room: blood pressure of 209/75 m...
Source: JEMS Patient Care - May 1, 2018 Category: Emergency Medicine Authors: Ken Davis, BA, EMT-P, FP-C Tags: Patient Care Cardiac & Resuscitation Source Type: news

Sickle Cell Trait Not Linked to Stroke in African - Americans
Meta - analysis of four cohorts shows sickle cell trait not linked to incidence of ischemic stroke (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 27, 2018 Category: Cancer & Oncology Tags: Cardiology, Neurology, Oncology, Pathology, Journal, Source Type: news

Sickle Cell Trait Not Linked to Stroke in African-Americans
FRIDAY, April 27, 2018 -- For African-Americans, sickle cell trait (SCT) seems not to be associated with the incidence of ischemic stroke, according to a meta-analysis published online April 23 in JAMA Neurology. Hyacinth I. Hyacinth, M.D., Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 27, 2018 Category: Pharmaceuticals Source Type: news

Previous Stroke Tied to Higher Risks in Aortic Valve Replacement
FRIDAY, April 27, 2018 -- For patients undergoing surgical aortic valve replacement (SAVR), previous stroke is a risk factor for recurrent ischemic stroke and major adverse cardiovascular events (MACE), according to a study published online April 25... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 27, 2018 Category: Pharmaceuticals Source Type: news